Seragene Therapeutics has received funding from Pathway to Cures, the venture philanthropy fund of the National Bleeding Disorders Foundation (NBDF), to advance the…
News
A 36-year-old woman in China with congenital thrombotic thrombocytopenic purpura (TTP) successfully delivered a healthy baby after preventive plasma therapy was started early in pregnancy,…
An assessment of platelet function, rather than platelet counts alone, may better reflect bleeding severity and treatment response in people with immune thrombocytopenia (ITP),…
Applications are now open for the 2026 Eric Dostie Memorial College Scholarships, which will award $1,000 each to 10 qualifying students whose lives have…
Adults with severe immune thrombotic thrombocytopenic purpura (TTP) who are at a high risk of bleeding may be managed in a hospital’s emergency department…
In a large, investigator-initiated clinical trial, about twice as many children and adolescents with newly diagnosed immune thrombocytopenia (ITP) achieved a sustained platelet response…
A 3-year-old boy in Texas was the first known person with two bleeding disorders — type 1 von Willebrand disease (VWD) and hemophilia…
A young man with unusual blood clots in the spleen was ultimately diagnosed with immune-mediated thrombotic thrombocytopenic purpura (TTP) — also known as acquired…
Oral hetrombopag safely boosts platelet counts and reduces bleeding and the need for rescue therapy in adults with persistent immune thrombocytopenia (ITP) who have…
The rare coexistence of von Willebrand disease (VWD) type 3 and factor V Leiden (FVL) can put patients at risk for…
